Recent immunomodulatory strategies in transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Regenerative Medicine

Background:

• Organ transplantation faces challenges with poor long-term survival and high mortality rates.
• Current immunosuppressive therapies have limitations, including significant toxicity.
• Optimizing transplant outcomes necessitates exploring alternative immunosuppression strategies.

Purpose of the Study:

• To review recent clinical advances in immunosuppressive therapies for organ transplantation.
• To highlight novel approaches for maintenance immunosuppression and organ rejection treatment.
• To discuss methods for minimizing toxicity associated with immunosuppression.

Main Methods:

• Review of recent clinical advancements in immunosuppressive therapies.
• Evaluation of novel stem cell-based therapies (mesenchymal stem cells, exosomes).
• Assessment of immunoisolation techniques and salvage therapies (photopheresis, total lymphoid irradiation).

Main Results:

• Emerging therapies like stem cells, phagosomes, and exosomes offer new avenues for immunosuppression.
• Immunoisolation techniques and salvage therapies present alternative treatment choices.
• Advances focus on novel drugs with mechanisms of action to minimize toxicity.

Conclusions:

• Newer immunosuppressive strategies are crucial for improving long-term organ transplant outcomes.
• Stem cell-based therapies and immunoisolation techniques show promise in reducing transplant-related mortality.
• Minimizing immunosuppressive toxicity is key to enhancing patient survival and allograft function.